e-Drug3D 598 |
PINACIDIL DISCONTINUED
|
cas 60560-33-0 |
CLASS CARDIOVASCULAR |
ROUTE (list) ORAL |
PK parameters F 57 PERCENT |
Target TARGET ATP-DEPENDENT POTASSIUM CHANNEL |
DrugCentral Sulfonylurea receptor 2, Kir6.2 UNIPROT O60706 ABCC9 |
Download SDF file | Guanidine, N-cyano-N'-4-pyridinyl-N''-(1,2,2-trimethylpropyl)- Formula: Calculated chemical properties: MW 245.33 NB_atoms 18 XLogP 2.35 PSA 58.453 NB_HD 2 NB_HA 5 fsp3 0.46 Lipinski(0=no;1=yes) 1 |
FDA NDA 019456 (pdf not found) INN (PINACIDIL) PINDAC (LEO PHARM) APPROVAL= AP YEAR= 1989 NEWMOLECULARENTITY DISCONTINUED |
Other links: |